Day One Biopharmaceuticals (DAWN) Free Cash Flow (2022 - 2025)
Day One Biopharmaceuticals (DAWN) has disclosed Free Cash Flow for 4 consecutive years, with -$14.1 million as the latest value for Q4 2025.
- For Q4 2025, Free Cash Flow rose 71.28% year-over-year to -$14.1 million; the TTM value through Dec 2025 reached -$104.1 million, down 6.08%, while the annual FY2025 figure was -$104.1 million, 6.08% down from the prior year.
- Free Cash Flow was -$14.1 million for Q4 2025 at Day One Biopharmaceuticals, down from -$6.1 million in the prior quarter.
- The five-year high for Free Cash Flow was $105.0 million in Q3 2024, with the low at -$104.1 million in Q2 2024.
- Historically, Free Cash Flow has averaged -$28.7 million across 4 years, with a median of -$32.6 million in 2022.
- Biggest YoY gain for Free Cash Flow was 382.99% in 2024; the steepest drop was 144.54% in 2024.
- Over 4 years, Free Cash Flow stood at -$35.3 million in 2022, then dropped by 17.1% to -$41.4 million in 2023, then dropped by 19.04% to -$49.3 million in 2024, then surged by 71.28% to -$14.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Free Cash Flow were -$14.1 million in Q4 2025, -$6.1 million in Q3 2025, and -$24.5 million in Q2 2025.